Healthcare ❯ Pharmaceuticals

Drug Manufacturing

Quality Control Tariffs Active Pharmaceutical Ingredients Biosimilars Market Trends Active Ingredients Weight Loss Drugs Supply Chain Domestic Production Research and Development

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

The upgrade positions the site to supply markets outside the U.S. ahead of a possible EMA decision on the Wegovy pill.

Telangana Orders Stop-Use of Almont-Kid Syrup After Ethylene Glycol Found

Trump Announces Drug-Price Pacts With 9 More Pharma Giants, Tariffs Paused for Three Years

ED Attaches Chennai Flats of Coldrif Maker in Toxic Cough Syrup Case

Pfizer Tops Q3 Forecasts, Raises Profit Outlook

FDA Drug Approvals Slowed in Q3 as Missed Deadlines and CRLs Rose

Merck Breaks Ground on $3 Billion Virginia Plant in $70 Billion U.S. Expansion

U.S. Imposes 100% Tariffs on Branded Drug Imports as Trump Unveils TrumpRx and Secures Pfizer Price Cuts

Celltrion Seals Deal to Buy Eli Lilly’s New Jersey Biologics Plant for $330 Million

Punjab Police Seal Roorkee and Haridwar Pharma Units in Cross-State Opioid Probe

Celltrion Named Preferred Bidder for U.S. Biopharmaceutical Plant to Avoid Tariffs

AstraZeneca CEO Considers Shifting Primary Listing to U.S.

Pharmaceutical Giants Grapple With Tariff Uncertainty as Roche Seeks Exemptions

Roche Announces $50 Billion U.S. Investment to Expand Manufacturing and R&D

Johnson & Johnson Launches $55 Billion U.S. Manufacturing and Research Expansion

Eli Lilly Announces $27 Billion Investment in U.S. Manufacturing Expansion

Johnson & Johnson Exceeds Q4 Expectations with Strong Cancer Drug Sales

Eli Lilly Names Lucas Montarce as New CFO Amid Expansion Efforts

Eli Lilly Invests $9 Billion to Boost Production of Weight Loss Drugs